503 filings
Page 13 of 26
6-K
hrxy9dcotcakk8kzw
5 Jan 23
Current report (foreign)
6:01am
6-K
fymy zo1iqd3td3uby08
29 Dec 22
Current report (foreign)
12:23pm
6-K
yt7zp5hl9p d36
29 Dec 22
Current report (foreign)
11:33am
6-K
4f9k9vkv 146y
23 Dec 22
Current report (foreign)
10:43am
6-K
h54n8nbcopt0k
23 Dec 22
Current report (foreign)
10:35am
6-K
b7zicyh4624
23 Dec 22
Current report (foreign)
10:29am
6-K
o9yibncu9ua22wea0ri0
23 Dec 22
Current report (foreign)
10:22am
6-K
b7qjkzsrmj ed
23 Dec 22
Current report (foreign)
10:12am
6-K
tmhg tkc06hhtspdljc
22 Dec 22
Current report (foreign)
10:51am
6-K
6fpna
22 Dec 22
Current report (foreign)
10:41am
6-K
ef7k2a5ropjd37zb
20 Dec 22
Current report (foreign)
4:09pm
6-K
bnedhnq7x klyzx9
15 Dec 22
Current report (foreign)
10:43am
6-K
upzr79h8
14 Dec 22
Current report (foreign)
11:19am
6-K
ircc 2bgtz
13 Dec 22
Current report (foreign)
11:55am
6-K
ubt8pzfjg8roo5di
13 Dec 22
Current report (foreign)
11:46am
6-K
lyoj0tbtp 5anizyojk
12 Dec 22
MorphoSys Presents Updated Tafasitamab Results in Newly Diagnosed DLBCL Patients from Final firstMIND Analysis at ASH 2022
6:14am
6-K
068qjcoq2kt79iqza
12 Dec 22
MorphoSys Presents New Longer-term Phase 2 Results on Pelabresib in Myelofibrosis, Including Potential Disease-Modifying Activity, at ASH 2022
6:04am
6-K
aw3mykks
6 Dec 22
Current report (foreign)
4:13pm
6-K
a5fe9a1sc z08
6 Dec 22
Current report (foreign)
10:10am
6-K
0k8hz2x tf7w6qqh
5 Dec 22
Current report (foreign)
10:26am